California Public Employees Retirement System Pro Qr Therapeutics N.V. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$5.75 - $7.59 $537,050 - $708,906	-93,400 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$3.58 - $4.85 $7,160 - $9,700	-2,000 Reduced 2.1%	93,400 $392,000
Q3 2020 Nov 05, 2020	BUY	$4.79 - $6.3 $58,917 - $77,490	12,300 Added 14.8%	95,400 $457,000
Q2 2020 Aug 12, 2020	BUY	$4.5 - $6.53 $149,850 - $217,449	33,300 Added 66.87%	83,100 $505,000
Q4 2019 Jan 27, 2020	BUY	$5.84 - $10.51 $290,832 - $523,398	49,800 New	49,800 $494,000
Q3 2019 Oct 31, 2019	SELL	$5.76 - $9.44 $59,466 - $97,458	-10,324 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$9.1 - $15.55 $192,674 - $329,240	-21,173 Reduced 67.22%	10,324 $94,000
Q1 2019 May 03, 2019	SELL	$12.5 - $18.48 $129,287 - $191,138	-10,343 Reduced 24.72%	31,497 $437,000
Q4 2018 Feb 08, 2019	BUY	$15.25 - $22.4 $638,060 - $937,215	41,840 New	41,840 $660,000

Others Institutions Holding PRQR

# of Institutions

Shares Held

17.6M

Call Options Held

37.7K

Put Options Held

21.3K

Privium Fund Management B.V.

5.63M
Shares

$13.4 Million
2.56% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

3.63M
Shares

$8.63 Million
0.01% of portfolio
Eco R1 Capital, LLC San Francisco, CA

1.84M
Shares

$4.37 Million
0.14% of portfolio
M28 Capital Management LP Stamford, CT

1.02M
Shares

$2.43 Million
1.76% of portfolio
Dafna Capital Management LLC Los Angeles, CA

906K
Shares

$2.16 Million
0.42% of portfolio

View Full List

About ProQR Therapeutics N.V.

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $170M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

More about PRQR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account